BACTERIOLOGICAL STUDY OF CEFMINOX IN THE FIELD OF OBSTETRICS AND GYNECOLOGY

Cefminox (CMNX, MT-141), a new cephem antibiotic, was determined of its antibacterial activity against 304 clinical isolates with following results. CMNX was inferior to CEZ or CMZ in the activity against 78 isolates of Staphylococcus sp., but it was superior to these antibiotics in the activity aga...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Japanese journal of antibiotics 1985/05/25, Vol.38(5), pp.1236-1240
Hauptverfasser:	OHBAYASHI, FUTOSHI, NINOMIYA, KEIU, YOSHIMOTO, TOSHIKO, HASEGAWA, YUKIO
Format:	Artikel
Sprache:	jpn
Schlagworte:	Bacteroides - drug effects Cefazolin - pharmacology Cefmetazole Cephamycins - pharmacology Drug Resistance, Microbial Escherichia coli - drug effects Female Genital Diseases, Female - microbiology Humans Peptococcus - drug effects Peptostreptococcus - drug effects Staphylococcus - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Cefminox (CMNX, MT-141), a new cephem antibiotic, was determined of its antibacterial activity against 304 clinical isolates with following results. CMNX was inferior to CEZ or CMZ in the activity against 78 isolates of Staphylococcus sp., but it was superior to these antibiotics in the activity against 104 isolates of E. coli. Against 53 isolates of Bacteroides sp., CMNX showed higher activity than CEZ or CMZ. In the activity against 69 isolates of Peptococcus sp. and Peptostreptococcus sp., CMNX was almost equal to CEZ.
ISSN:	0368-2781 2186-5477
DOI:	10.11553/antibiotics1968b.38.1236